Carle Health Urologist, Dr. Robert Lai, discussed Overactive Bladder (OAB) during Overactive Bladder Awareness Month.

BEL AIR, Md. — Marc Hickel thought his battle with prostate cancer was over after surgery and radiation treatment. But five years later, scarring from the radiation created new, debilitating problems ...

NMIBC treatment varies by tumor stage, grade, and prior therapies, with high-risk cases often requiring radical cystectomy. Bladder-preserving approaches include intravesical therapies like BCG, ...

Rectal diazepam pretreatment led to a 78% relative risk reduction in drug retention failure and a 68% reduction in bladder spasms, improving treatment consistency and reducing drug waste. The study ...

A treatment’s safety and efficacy remain the gold standard in therapeutic innovation, but the most transformative medicines also succeed on another critical front: how seamlessly they integrate into a ...

NEW HAVEN, Conn. (WTNH) — The FDA recently approved the first breakthrough treatment for bladder cancer in 40 years. It comes at a time when Coach Prime – Deion Sanders – is sharing his bladder cancer ...

Please provide your email address to receive an email when new articles are posted on . Most patients with non-muscle-invasive bladder cancer who received TAR-200 with gemcitabine achieved complete ...

Bladder cancer patients who have an early but aggressive form of the disease that’s unresponsive to the standard of care now have a new treatment option, an implanted Johnson & Johnson drug/device ...

The US Food and Drug Administration has approved Johnson & Johnson’s drug delivery system for a type of bladder cancer, offering a potential surgery-free option for patients. The drug release system, ...

NEW YORK CITY — The U.S. Food and Drug Administration has approved Johnson & Johnson's drug delivery system for patients with a type of bladder cancer, the drugmaker said on Tuesday, offering a ...

Inlexzo is a new treatment for a type of bladder cancer in adults that hasn’t spread to the muscles and doesn’t respond to Bacillus Calmette-Guérin (BCG) therapy. It’s approved for treating non-muscle ...